Aghakhani K

Galland F

Matsko DE

Mazal PR

Metindir J

Paredes J

 This study used immunohistochemical methods for detecting the expression of E-cadherin and β-catenin in pituitary adenoma. Specimens were collected from 91 cases. EnVision was used for immunohistochemical staining. The results were graded depending on the staining intensity and range. Associations between E-cadherin and β-catenin expression and tumor subtype, invasiveness, and postoperative recurrence were investigated. There was a significant downregulation of E-cadherin and β-catenin in growth hormone (GH)-type tumors when compared with prolactin-type tumors ( uc = 2.693 and 2.109, respectively; P &lt; .05). E-cadherin and β-catenin were downregulated in invasive pituitary adenomas ( uc = 3.563 and 4.166, respectively; P &lt; .05) and in clinically recurring pituitary adenomas ( uc = 2.871 and 3.866, respectively; P &lt; .05). There was no difference in the percentage of invasive prolactin and GH secreting tumors (28.57% and 22.86%, respectively; P &gt; .05). The expression of E-cadherin and β-catenin in pituitary adenoma was significantly downregulated and related to subtype, invasiveness, and postoperative recurrence. </jats:p

Expression and Significance of E-Cadherin and β-Catenins in Pituitary Adenoma

Abstract

Similar works

Full text

Available Versions

Crossref